CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 94 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | -91.8% | 1,953 | -90.2% | 0.00% | – |
| Q4 2020 | $61,000 | +258.8% | 19,988 | +635.4% | 0.00% | – |
| Q3 2020 | $17,000 | -19.0% | 2,718 | -21.1% | 0.00% | – |
| Q2 2020 | $21,000 | +75.0% | 3,445 | -28.6% | 0.00% | – |
| Q1 2020 | $12,000 | -25.0% | 4,826 | -20.5% | 0.00% | – |
| Q4 2019 | $16,000 | -74.6% | 6,074 | +17.3% | 0.00% | – |
| Q3 2019 | $63,000 | -31.5% | 5,176 | -35.5% | 0.00% | – |
| Q2 2019 | $92,000 | – | 8,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 325,000 | $861,000 | 4.66% |
| MFN Partners Management, LP | 2,427,677 | $6,433,000 | 0.85% |
| EcoR1 Capital, LLC | 2,742,276 | $7,267,000 | 0.76% |
| Slate Path Capital LP | 1,196,063 | $3,170,000 | 0.24% |
| Eversept Partners, LP | 337,145 | $893,434 | 0.22% |
| Artal Group S.A. | 1,861,584 | $4,933,000 | 0.21% |
| Alambic Investment Management, L.P. | 21,265 | $56,000 | 0.14% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $525,000 | 0.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 124,976 | $331,000 | 0.04% |
| Broderick Brian C | 32,175 | $86,000 | 0.03% |